Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
Sofgen Pharma Market Cap
Sofgen Pharma has a market cap or net worth of $239.27 thousand as of September 8, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
239.27K
Enterprise Value
275.75M
Revenue
373.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since December 9, 2019, Sofgen Pharma's market cap has decreased from 239.85M to 239.27K, a decrease of -99.90%. That is a compound annual growth rate of -64.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 239.27K | -99.59% |
| Dec 31, 2025 | 57.83M | -78.10% |
| Dec 31, 2024 | 264.01M | -42.51% |
| Dec 29, 2023 | 459.19M | -22.48% |
| Dec 30, 2022 | 592.33M | -46.15% |
| Dec 31, 2021 | 1.10B | 323.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Galexxy Holdings | 369.61K |
| Fifty 1 Labs | 355.46K |
| Neutra | 304.29K |
| Alterola Biotech | 296.25K |
| Petros Pharmaceuticals | 254.23K |
| ViaDerma | 246.74K |
| Body and Mind | 238.41K |
| Trafalgar International | 228.71K |